Disc Medicine, Inc. (IRON) vs Nurix Therapeutics, Inc. (NRIX)
A side-by-side comparison of Disc Medicine, Inc. and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IRON
Disc Medicine, Inc.
$61.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NRIX
Nurix Therapeutics, Inc.
$22.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IRON vs NRIX
growth of $100 · dividends reinvested · last 6yIRON -38.5% (-7.8%/yr)NRIX +42.6% (+6.1%/yr)NRIX compounded faster over this window
IRON NRIX
IRON vs NRIX: by the numbers
- •IRON is the larger company ($2.37B vs $2.35B market cap).
- •Both run net losses; IRON's is the smaller (0.00% vs -928.44% net margin).
Metrics side by side
Valuation
| Metric | IRON | NRIX |
|---|---|---|
| P/S ratio | N/A | 63.79 |
| P/B ratio | 3.67 | 5.83 |
Profitability
| Metric | IRON | NRIX |
|---|---|---|
| Gross margin | 0.00% | 77.55% |
| Operating margin | 0.00% | -340.16% |
| Net margin | 0.00% | -928.44% |
| ROE | -38.17% | -84.78% |
| ROIC | -38.21% | -77.92% |
Growth (annualized)
| Metric | IRON | NRIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 9.96% |
| Total return CAGR (5Y) | 10.70% | -5.51% |
Frequently asked
- How have IRON and NRIX total returns compared?
- Over the past 5 years, IRON delivered 10.70% and NRIX delivered -5.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.